Heska Stock News

The Veterinary Ultrasound Market research report provides broad, subjective bits of knowledge on the potential and specialty portions or regions displaying good growth. The Veterinary Ultrasound Market research report comprehensively investigates the current and developing business sector patterns and openings

Analysts predict that Heska Co. (NASDAQ:HSKA) will announce $65.89 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for Heskas earnings. The lowest sales estimate is $65.70 million and the highest is $66.07 million. Heska reported sales of $64.32 million during the same quarter last year, which indicates a positive []

Related Stocks: HSKA ,

Wall Street brokerages predict that Heska Co. (NASDAQ:HSKA) will post $0.26 earnings per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Heskas earnings, with the highest EPS estimate coming in at $0.32 and the lowest estimate coming in at $0.19. Heska posted earnings of $0.72 per share in the []

Zacks Investment Research cut shares of Heska (NASDAQ:HSKA) from a hold rating to a strong sell rating in a research report released on Friday morning, Zacks.com reports. According to Zacks, Heska Corporation sells advanced veterinary diagnostic and specialty products. Heskas state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data []

Charles Schwab Investment Management Inc. lifted its position in shares of Heska Co. (NASDAQ:HSKA) by 10.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 67,683 shares of the medical research companys stock after acquiring an additional 6,380 shares during the period. Charles Schwab Investment Management Inc.s holdings in Heska were worth $15,549,000 as of []

Heska Corp Brands, Inc. (HSKA) CEO Kevin Wilson on Q3 2021 Results - Earnings Call Transcript

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. The post 7 A-Rated Healthcare Stocks to Buy for the Long Haul appear

Shares of Heska Corp (NASDAQ: HSKA) have lost nearly 20% since late August, but Spruce Point Capital Management says the stock could crash another 60% from here as its current premium valuation is “

Heska Corporation (HSKA) CEO Kevin Wilson on Q2 2021 Results - Earnings Call Transcript

The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across d

Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?

These seven small-cap stocks have the potential of rebounding and making it big in the post-pandemic reality of 2021. The post 7 Small-Cap Stocks To Buy for Their Big Ambitions appeared first on Inves

Heska's (HSKA) CEO Kevin Wilson on Q1 2021 Results - Earnings Call Transcript

Heska (HSKA) delivered earnings and revenue surprises of 555.56% and 11.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?